$15.90
N/A
Last update: Nov 2, 4:26 PM
Beta Bionics Inc
BBNXNASDAQ
Beta Bionics (BBNX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Beta Bionics (BBNX) last issued guidance on October 27, 2026 for fiscal year 2026. The company guided revenue in the range of $124M - $126M for the period.
Compared to prior guidance, Beta Bionics raised its revenue forecast from a prior range of $121M - $126M.
Beta Bionics has issued 8 guidance updates between March 25, 2025 and October 27, 2026. During this period, the company raised its outlook 4 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.52 | $-0.56 | $-0.48 | $-0.39 |
| Actual | $-0.52 | $-0.53 | $-0.49 | $-0.30 |
| Surprise | 0.00% | +5.36% | -2.08% | +23.1% |
| Revenue | ||||
| Estimate | $34.7M | $31.5M | $27.3M | $31.5M |
| Actual | $35.5M | $32.0M | $27.6M | $32.1M |
| Surprise | +2.30% | +1.58% | +1.27% | +2.04% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.44 | $-0.53 | $-0.50 | $-0.63 |
| Revenue | ||||
| Consensus | $30.5M | $36.1M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $-0.52 | $-0.52 | 0.00 % |
| Q2 | Jul 29, 2026 | $-0.53 | $-0.56 | 5.36 % |
| Q1 | Apr 21, 2026 | $-0.49 | $-0.48 | -2.08 % |
| Q4 | Feb 17, 2026 | $-0.30 | $-0.39 | 23.1 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $35.51M | $34.71M | 2.30 % |
| Q2 | Jul 29, 2026 | $32.01M | $31.51M | 1.58 % |
| Q1 | Apr 21, 2026 | $27.63M | $27.28M | 1.27 % |
| Q4 | Feb 17, 2026 | $32.12M | $31.48M | 2.04 % |
